Plasma homovanillic acid levels and therapeutic outcome in schizophrenics: comparisons of neuroleptic-naive first-episode patients and patients with disease exacerbation due to neuroleptic discontinuance.

Akiyama, K; Tsuchida, K; Kanzaki, A; Ujike, H; Hamamura, T; Kondo, K; Mutoh, S; Miyanagi, K; Kuroda, S; Otsuki, S

Akiyama, K; Tsuchida, K; Kanzaki, A; Ujike, H; Hamamura, T; Kondo, K; Mutoh, S; Miyanagi, K; Kuroda, S; Otsuki, S.

Affiliation

Akiyama K; Department of Neuropsychiatry, Okayama University Medical School, Japan.

Biol Psychiatry ; 38(10): 639-48, 1995 Nov 15.

Article in En | MEDLINE | ID: mdl-8555375

Subject(s)

Antipsychotic Agents/therapeutic use; Fluphenazine/therapeutic use; Haloperidol/therapeutic use; Homovanillic Acid/blood; Schizophrenia/blood; Schizophrenia/drug therapy; Adult; Analysis of Variance; Brief Psychiatric Rating Scale; Female; Humans; Male; Schizophrenia/physiopathology; Statistics, Nonparametric; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Antipsychotic Agents / Fluphenazine / Haloperidol / Homovanillic Acid Type of study: Guideline / Prognostic_studies Limits: Adult / Female / Humans / Male Language: En Journal: Biol Psychiatry Year: 1995 Type: Article Affiliation country: Japan

Search on Google

XML

PubMed Links